Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H ( (HK:1558) ) is now available.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. has announced the successful fulfillment of all conditions for its merger with Sunshine Lake Pharma Co., Ltd., making the merger effective. This development marks a significant step in the company’s strategic operations, potentially enhancing its market positioning and operational capabilities. Additionally, an agent has been appointed to facilitate the trading of odd lots of the Offeror H Shares, ensuring smoother transactions for shareholders during the specified period.
The most recent analyst rating on (HK:1558) stock is a Buy with a HK$13.80 price target. To see the full list of analyst forecasts on YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H stock, see the HK:1558 Stock Forecast page.
More about YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. is a pharmaceutical company based in the People’s Republic of China. It operates in the healthcare industry, focusing on the development and manufacturing of pharmaceutical products.
Average Trading Volume: 9,815,063
Technical Sentiment Signal: Buy
Current Market Cap: HK$12.65B
Learn more about 1558 stock on TipRanks’ Stock Analysis page.